NO994261L - Fremgangsmåte for fremstilling av trovafloxacinsyresalter - Google Patents

Fremgangsmåte for fremstilling av trovafloxacinsyresalter

Info

Publication number
NO994261L
NO994261L NO994261A NO994261A NO994261L NO 994261 L NO994261 L NO 994261L NO 994261 A NO994261 A NO 994261A NO 994261 A NO994261 A NO 994261A NO 994261 L NO994261 L NO 994261L
Authority
NO
Norway
Prior art keywords
trovafloxacinic
preparation
acid salts
salts
acid
Prior art date
Application number
NO994261A
Other languages
English (en)
Norwegian (no)
Other versions
NO994261D0 (no
Inventor
Timothy Norris
Peter Robert Rose
Keith Michael Devries
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO994261D0 publication Critical patent/NO994261D0/no
Publication of NO994261L publication Critical patent/NO994261L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO994261A 1998-09-03 1999-09-02 Fremgangsmåte for fremstilling av trovafloxacinsyresalter NO994261L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (2)

Publication Number Publication Date
NO994261D0 NO994261D0 (no) 1999-09-02
NO994261L true NO994261L (no) 2000-03-06

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994261A NO994261L (no) 1998-09-03 1999-09-02 Fremgangsmåte for fremstilling av trovafloxacinsyresalter

Country Status (40)

Country Link
US (1) US6359137B1 (xx)
EP (1) EP0989119A1 (xx)
JP (1) JP3354526B2 (xx)
KR (1) KR20000022858A (xx)
CN (1) CN1248580A (xx)
AP (1) AP1118A (xx)
AR (1) AR021475A1 (xx)
AU (1) AU761035B2 (xx)
BG (1) BG103703A (xx)
BR (1) BR9904082A (xx)
CA (1) CA2281244C (xx)
CO (1) CO5251466A1 (xx)
EA (1) EA002340B1 (xx)
EE (1) EE04118B1 (xx)
GE (1) GEP20022785B (xx)
GT (1) GT199900142A (xx)
HN (1) HN1999000141A (xx)
HR (1) HRP990274A2 (xx)
HU (1) HUP9902967A3 (xx)
ID (1) ID23718A (xx)
IL (1) IL131614A0 (xx)
IN (1) IN191583B (xx)
IS (1) IS5168A (xx)
MA (1) MA24966A1 (xx)
MY (1) MY130800A (xx)
NO (1) NO994261L (xx)
NZ (1) NZ337605A (xx)
OA (1) OA11152A (xx)
PA (1) PA8481001A1 (xx)
PE (1) PE20001026A1 (xx)
PL (1) PL335246A1 (xx)
SG (1) SG74748A1 (xx)
SK (1) SK116599A3 (xx)
SV (1) SV1999000144A (xx)
TN (1) TNSN99164A1 (xx)
TR (1) TR199902138A2 (xx)
TW (1) TW520369B (xx)
UY (1) UY25686A1 (xx)
YU (1) YU43199A (xx)
ZA (1) ZA995630B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
WO1995019361A1 (en) * 1994-01-18 1995-07-20 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
EP0789697B1 (en) * 1995-06-06 1998-06-17 Pfizer Inc. CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
SG74748A1 (en) 2000-08-22
AP9901667A0 (en) 1999-12-31
CN1248580A (zh) 2000-03-29
NZ337605A (en) 2001-03-30
EA199900708A3 (ru) 2000-08-28
AP1118A (en) 2002-11-21
HUP9902967A2 (hu) 2000-05-28
MA24966A1 (fr) 2000-04-01
BR9904082A (pt) 2000-09-12
PE20001026A1 (es) 2000-10-11
ID23718A (id) 2000-05-11
MY130800A (en) 2007-07-31
AR021475A1 (es) 2002-07-24
AU761035B2 (en) 2003-05-29
EP0989119A1 (en) 2000-03-29
PL335246A1 (en) 2000-03-13
US6359137B1 (en) 2002-03-19
JP3354526B2 (ja) 2002-12-09
EA002340B1 (ru) 2002-04-25
HRP990274A2 (en) 2000-10-31
UY25686A1 (es) 2000-03-31
BG103703A (bg) 2001-08-31
CO5251466A1 (es) 2003-02-28
TW520369B (en) 2003-02-11
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
SK116599A3 (en) 2000-05-16
ZA995630B (en) 2001-03-01
NO994261D0 (no) 1999-09-02
TR199902138A2 (xx) 2000-04-21
IS5168A (is) 2000-03-04
IL131614A0 (en) 2001-01-28
GT199900142A (es) 2001-02-15
EE9900457A (et) 2000-04-17
TNSN99164A1 (fr) 2005-11-10
SV1999000144A (es) 2000-09-05
CA2281244C (en) 2003-05-20
AU4482699A (en) 2000-03-16
HU9902967D0 (en) 1999-10-28
CA2281244A1 (en) 2000-03-03
IN191583B (xx) 2003-12-06
PA8481001A1 (es) 2000-09-29
GEP20022785B (en) 2002-09-25
HUP9902967A3 (en) 2000-11-28
EE04118B1 (et) 2003-08-15
YU43199A (sh) 2002-11-15
HN1999000141A (es) 2000-06-19
EA199900708A2 (ru) 2000-04-24
JP2000086658A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
NO20010365D0 (no) Fremgangsmåte for fremstilling av orto-alkylerte benzosyrederivater
FI963050A (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
NO20021368D0 (no) Fremgangsmåte for fremstilling av fenyleddiksyre-derivater
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
HUP9900344A3 (en) Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO991672D0 (no) FremgangsmÕte for fremstilling av hydroksaminsyrer
IT1303759B1 (it) Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
NO20021727D0 (no) Fremgangsmåte for fremstilling av 3,4-metylen-dioksy- mandelisk syre
NO994261L (no) Fremgangsmåte for fremstilling av trovafloxacinsyresalter
NO20006073D0 (no) Fremgangsmåte for fremstilling av krystallinske salter av amoxycillin
DK0782982T3 (da) Fremgangsmåde til fremstilling af o-chlormethyl-phenylglyoxylsyrederivater
DK0717046T3 (da) Fremgangsmåde til fremstilling af phosphonsyrederivater
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO995841D0 (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2-fenylpropionsyre-derivater
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
NO994793L (no) Fremgangsmåte for fremstilling av clavulansyre
NO20011499D0 (no) FremgangsmÕte for fremstilling av 6,6-dialkoksy-5-hydroksy-3- oksoheksansyreestere
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO991098L (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
FR2767822B1 (fr) Procede de preparation de composes de type arylaminoalkylidenemalonates